GOSS
Gossamer Bio, Inc. Common StockstockNASDAQ
At CloseOct 19, 2026 3:59:51 PM EDT
8.35USD-4.789%(-0.42)179,314
GOSS Financials
In Q2 FY 2026 (ended ), Gossamer Bio, Inc. Common Stock (GOSS) reported revenue of $9.24M, net income of $16.9M, operating cash flow of −$39.42M, and assets of $76.87M.
Loading business breakdowns…